Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Novolyte Technologies was a leading global manufacturer of specialty chemicals and high-performance electrolyte formulations. The company was primarily recognized for its expertise in lithium-ion battery electrolytes, serving the rapidly growing energy storage and electric vehicle markets. Additionally, Novolyte operated a significant pharmaceutical and specialty chemicals division that produced organophosphorus compounds and other intermediates used in drug synthesis. Headquartered in Cleveland, Ohio, the company maintained strategic manufacturing operations in Baton Rouge, Louisiana, and Suzhou, China. Novolyte was established in 2008 as a portfolio company of Arsenal Capital Partners following the acquisition of Ferro Corporation's specialty chemicals business. In 2012, the company was acquired by BASF, integrating its technology into BASF’s battery materials and electronic materials units.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Novolyte Technologies.